Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-27 @ 2:24 PM
Study NCT ID:
NCT04757857
Status:
TERMINATED
Last Update Posted:
2023-01-25
First Post:
2021-02-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
COVID-19 Antithrombotic Rivaroxaban Evaluation
Sponsor:
Hospital Alemão Oswaldo Cruz
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-08
First Submit QC Date:
None
Study First Post Date:
2021-02-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-20
Last Update Post Date:
2023-01-25
Last Update Post Date Type:
ACTUAL